C. Hudon et al., CHARACTERISTICS OF BRONCHIAL-ASTHMA WITH INCOMPLETE REVERSIBILITY OF AIR-FLOW OBSTRUCTION, Annals of allergy, asthma, & immunology, 78(2), 1997, pp. 195-202
Background: Incomplete reversibility of airflow obstruction (IRAO) can
be observed in some asthmatic patients without significant smoking hi
story nor evidence of other respiratory condition. The characteristics
of this group remain however to be defined. Methods: We compared 18 a
sthmatic patients with persistent airflow obstruction, defined as an F
EV(1) less than or equal to 75% predicted despite optimal corticostero
id treatment, to others with complete reversibility of airflow obstruc
tion, paired for age and gender (CRAO, FEV(1) > 80% of predicted). Res
ults: Mean duration of asthma was 31.6 years for IRAO patients and 17.
7 for the CRAO group and mean baseline FEV(1) was 48.6 +/- 2.6% and 89
.3 +/- 3.4%, respectively. Patients with IRAO had more severe airflow
obstruction and hyper inflation than those with CRAO, while lung compl
iance and CO diffusion were similar. Overall healthcare use was simila
r in the two groups, but those with IRAO had a greater global asthma-r
elated discomfort, increased diurnal variation of airflow obstruction
and used higher doses of inhaled corticosteroids than those with CRAO.
Patients with IRAO had slightly increased airway wall thickness on hi
gh resolution chest tomography compared with CRAO. Baseline FEV(1), ho
wever, was not correlated with the measured airway wall thickness. Con
clusion: We found that asthmatic patients with IRAO have a more severe
asthma and asthma of longer duration than asthmatic subjects with CRA
O. Our data suggest that in asthma, IRAO may result from long-standing
airway inflammation and associated structural changes, although this
remains to be further documented.